LabCentral signs Science Exchange: outsourced services ‘increasingly important’

By Melissa Fassbender

- Last updated on GMT

(Image: iStock/ChristianChan)
(Image: iStock/ChristianChan)

Related tags Science exchange Outsourcing

Cambridge-based LabCentral has signed on Science Exchange to provide its resident startups with access to outsourced services.

LabCentral is a shared laboratory workspace for life-sciences and biotech startups in Kendall Square.

With access to the Science Exchange​ marketplace, the startups will have access to more than 2,500 service providers that have been qualified through the ISO 9001-certified evaluation process.

The use of outsourced services is becoming increasingly important to life science and biotech companies large and small, and that’s true for our resident start-ups​,” Johannes Fruehauf, LabCentral co-founder and president told Outsourcing-Pharma.com.

Science Exchange has developed a unique ‘no-headache’ platform to streamline the process – making it easy to access services without having to negotiate each individual transaction​,” he added. “That was very attractive to us, since we’re all about removing barriers to help our companies meet their milestones faster and cost-effectively​.”

Science Exchange was certified under the EU-US Privacy Shield Framework​ in July of this year after completing a seven-step process to demonstrate compliance with various data protection requirements.

Also in July, the company partnered with IndieBio​ to provide the incubator with its services.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Related suppliers

Follow us

Products

View more

Webinars